← Back to Clinical Trials
Recruiting NCT03998059
Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients
Trial Parameters
Condition Thrombocytopenia
Sponsor Institute of Hematology & Blood Diseases Hospital, China
Study Type OBSERVATIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 18 Years
Max Age 60 Years
Start Date 2019-01-23
Completion 2022-01-23
All Conditions
Interventions
splenectomy
Brief Summary
Evaluation of immune status before and after splenectomy in immune thrombocytopenia patients.
Eligibility Criteria
Inclusion Criteria: * Aged 18 to 60 years old, male or female; * Conform to the diagnostic criteria of immune Thrombocytopenia (ITP) * Needed splenectomy; * People who are willing to sign the informed consent voluntarily and follow the research program. Exclusion Criteria: * Secondary thrombocytopenic purpura; * Patients with poor compliance; * Researchers believe that patients should not participate in the test of any other condition.
Related Trials
NCT05255003
STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis
View Trial →
NCT02707497
The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thromboc
View Trial →
NCT03998059
Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients
View Trial →